Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
4.55M
-
Shares change
-
-58.1K
-
Total reported value, excl. options
-
$50.1M
-
Value change
-
-$170K
-
Put/Call ratio
-
1.19
-
Number of buys
-
30
-
Number of sells
-
-12
-
Price
-
$10.87
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q4 2019
57 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q4 2019.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.55M shares
of 27.1M outstanding shares and own 16.78% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (1.38M shares), DFPG INVESTMENTS, LLC (456K shares), FMR LLC (400K shares), Sumitomo Mitsui Trust Holdings, Inc. (281K shares), Nikko Asset Management Americas, Inc. (281K shares), DAFNA Capital Management LLC (174K shares), MORGAN STANLEY (159K shares), VANGUARD GROUP INC (124K shares), ROYCE & ASSOCIATES LP (106K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (89.2K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.